KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Yeon Hee Park

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 19건 중 1-19 번을 표시중입니다.

1 Article A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer 정경해 ; Cassandra Slader ; Chien-Ting Liu ; et al 2021
2 Article A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer 정경해 ; Cassandra Slader ; Chien-Ting Liu ; et al 2021
3 Article A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03) Dae-Won Lee ; Bhumsuk Keam ; Keun Seok Lee ; et al 2023
4 Article Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16) Se Hyun Kim ; Seock-Ah Im ; Koung Jin Suh ; et al 2023
5 Article Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel Joanne Wing Yan Chiu ; Soo Chin Lee ; James Chung-man Ho ; et al 2023
6 Article Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib 정경해 ; Jee Hyun Kim 7 ; Ji-Yeon Kim ; et al 2020
7 Article Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer Peter Schmid ; Javier Cortes ; Rebecca Dent ; et al 2022
8 Article Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer Soohyeon Lee ; Kyunghee Park ; Gun Min Kim ; et al 2022
9 Article Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer Kyoungmin Lee ; Jongwon Lee ; Jungmin Choi ; et al 2023
10 Article Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer Changhwan Sung ; Jinhyeon An ; Soohyeon Lee ; et al 2023
11 Article Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physicians Soo Yeon Baek ; Kyung-Hun Lee ; Sung-Bae Kim ; et al 2023
12 Article Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10) 고수진 ; 정경해 ; Gun Min Kim ; et al 2020
13 Article Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial Masato Takahashi ; Javier Cortés ; Rebecca Dent ; et al 2023
14 Article Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B) Sung Hoon Sim ; Jeong Eun Kim ; Min Hwan Kim ; et al 2022
15 Article Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13) 안진희 ; 오호석 ; 정경해 ; et al 2021
16 Article Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer Hee Kyung Ahn ; Sung Hoon Sim ; Koung Jin Suh ; et al 2022
17 Article Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis Guy Jerusalem ; Yeon Hee Park ; Toshinari Yamashita ; et al 2022
18 Article Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer Shanu Modi ; William Jacot ; Toshinari Yamashita ; et al 2022
19 Article Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial Fabrice André ; Yeon Hee Park ; Sung-Bae Kim ; et al 2023

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.